Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prolactinoma × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 3 Interventional 1

Sponsor

Conditions

Breast Neoplasms 852 Neoplasms 654 Carcinoma, Non-Small-Cell Lung 640 Prostatic Neoplasms 525 Colorectal Neoplasms 424 Lung Neoplasms 382 Neoplasm Metastasis 329 Multiple Myeloma 308 Leukemia, Myeloid, Acute 303 Ovarian Neoplasms 283 Melanoma 256 Squamous Cell Carcinoma of Head and Neck 233 Pancreatic Neoplasms 224 Recurrence 208 Brain Neoplasms 186 Glioblastoma 183 Stomach Neoplasms 178 Triple Negative Breast Neoplasms 176 Carcinoma, Hepatocellular 175 Uterine Cervical Neoplasms 169 Endometrial Neoplasms 169 Lymphoma 165 Precursor Cell Lymphoblastic Leukemia-Lymphoma 160 Head and Neck Neoplasms 159 Carcinoma, Renal Cell 152 Urinary Bladder Neoplasms 146 Leukemia, Lymphocytic, Chronic, B-Cell 139 Lymphoma, Non-Hodgkin 136 Lymphoma, Large B-Cell, Diffuse 133 Glioma 133

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting

Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡